Skip to main content
SpringerLink
Log in

Whole Body Hyperthermia and Intraperitoneal Carboplatin in Residual Ovarian Cancer

  • Chapter
Consensus on Hyperthermia for the 1990s

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 267))

Abstract

Intraperitoneal (IP) cisplatin-based chemotherapy provides prolonged disease-free survival in some women with residual peritoneal ovarian cancer following systemic chemotherapy. This review presents several considerations which support the combined use of IP carboplatin and whole body hyperthermia in this patient population. This novel treatment approach is predicated on projected advantages which relate to improved therapeutic index.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Andrews, P.A., Velury, S., Mann, S.C., and Howell, S.B. cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res. 48: 68–73, 1988.

    PubMed  CAS  Google Scholar 

  2. Barlogie, B., Corry, P.M., and Drewinko, B. In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C. Cancer Res. 40:1165–1168, 1980.

    PubMed  CAS  Google Scholar 

  3. Calvert, A.H., Harland, S.J., Newell, D.R., Siddik, Z.H., Jones, A.C., McElwain, P.G., Raju, S., Wiltshaw, E., Smith, I.E., Baker, J.M., Peckham, M.J., and Harrap, K.R. Early clinical studies with cisdiammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother. Pharmacol. 9: 140–147, 1982.

    CAS  Google Scholar 

  4. Cohen, J.D., and Robins, H.I. Hyperthermie enhancement of cisdiammine-1,1-cyclobutane dicarboxylate platinum(II) cytotoxicity in human leukemia cells in vitro. Cancer Res. 47: 4335–4337, 1987.

    PubMed  CAS  Google Scholar 

  5. Cohen, J.D., Robins, H.I., and Schmitt, C.L. Interactions of hyperthermia with carboplatin, cisplatin, and etoposide in human leukemia cells in vitro. Cancer Letters, in press.

    Google Scholar 

  6. Curt, G.A., Grygiel, J.J., Corden, B.J., Ozols, R.F., Weiss, R.B., Tell, D.T., Myers, C.E., and Collins, J.M. A Phase I and pharmacokinetic study of diamminecyclobutanedicarboxylatoplatinum (NSC 241240). Cancer Res. 43: 4470–4473, 1983.

    PubMed  CAS  Google Scholar 

  7. Decker, D.G., Fleming, T.R., Malkasian, G.D. et al. Cyclophosphamide plus cisplatinum in combination: Treatment program for stage III or IV ovarian carcinoma. Obstetrics and Gynecology 60: 481–487, 1982.

    PubMed  CAS  Google Scholar 

  8. Dedrick, R.L., Myers, C.E., Bungay, P.M., and DeVita, V.T. Jr. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat. Rep. 62: 1–11, 1978.

    PubMed  CAS  Google Scholar 

  9. Eichholtz-Wirth, H., and Hietel, B. The relationship between cisplatin sensitivity and drug uptake into mammalian cells in vitro. Brit. J. Cancer 54: 239–243, 1986.

    Article  PubMed  CAS  Google Scholar 

  10. Fisher, G., and Hahn, G.M. Enhancement of cis-platinum(II)diarrminedichloride cytotoxicity by hyperthermia. National Cancer Institute Monographs 61: 255–257, 1982.

    CAS  Google Scholar 

  11. Gerad, H., Egorin, M.J., Whitacre, M., Van Echo, D.A., and Aisner, J. Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum(II) and whole body hyperthermia. Cancer Chemotherapy and Pharmacology 11: 162–166, 1983.

    Article  PubMed  CAS  Google Scholar 

  12. Howell, S.B., Pfeifle, C.L., Wung, W.E., Olshen, R.A., Lucas, W.E., Yon, J.L., and Green, M. Intraperitoneal cisplatin with systemic thiosulfate protection. Ann. Int. Med. 97: 845–851, 1982.

    CAS  Google Scholar 

  13. Howell, S.B., Zimm, S., Markman, M., Abramson, I.S., Cleary, S., Lucas, W.E., and Weiss, R.J. Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy. J. Clin. Oncol. 5: 1607–1612, 1987.

    PubMed  CAS  Google Scholar 

  14. Hugander, A., Robins, H.I., Martin, P., and Schmitt, C. Temperature distribution during radiant heat whole-body hyperthermia: experimental studies in the dog. Int. J. Hypertherm. 3: 199–208, 1987.

    Article  CAS  Google Scholar 

  15. Joss, R.A., Kaplan, S., Goldhirsch, A., Sessa, C., Brunner, K.W., and Cavalli, F. A Phase I trial of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five-week schedule. Invest. New Drugs 2: 297–304, 1984.

    Article  PubMed  CAS  Google Scholar 

  16. Koeller, J.M., Trump, D.L., Tutsch, K.D., Earhart, R.H., Davis, T.E., Tormey, D.C. Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusion. Cancer 57: 222–225, 1986.

    Article  PubMed  CAS  Google Scholar 

  17. Kraker, A.J., and Moore, C.W. Accumulation of cis-diamminedichloroplatinum(II) and platinum analogues by platinum-resistant murine leukemia cells in vitro. Cancer Res. 48: 9–13, 1988.

    PubMed  CAS  Google Scholar 

  18. Lambert, H.E., and Berry, R.J. High dose cisplatin compared with high dose cyclophosphamide in the management of advanced epithelial ovarian cancer (FIGO stages III and IV): Report from the North Thames Cooperative Group. Brit. Med. J. 290: 889–893, 1985.

    CAS  Google Scholar 

  19. Levin, L., and Hryniuk, W.M. Dose intensity analysis of chemotherapy regimens in ovarian carcinoma. J. Clin. Oncol. 5: 756–767, 1987.

    PubMed  CAS  Google Scholar 

  20. Markman, M., Cleary, S., and Howells, S.B. Nephrotoxicity of high-dose intracavitary cisplatin with intravenous thiosulfate protection. Eur. J. Clin. Oncol. 21: 1015–1018, 1985.

    Article  CAS  Google Scholar 

  21. McVie, J.G., Dikhoff, T., Van der Heide, J., et al. Tissue concentra- tion of platinum after intraperitoneal cisplatin administration in patients. Abstract, Proc. Amer. Assoc. Cancer Res. 26: 162, 1985.

    Google Scholar 

  22. McVie, J.G., ten Bokkel Huinink, W.W., Dubbelman, R., Franklin, H., van der Vijgh, W., and Klein, I. Phase I study and pharmacokinetics of intraperitoneal carboplatin. Cancer Treat. Rev. 12: 35–41, 1985.

    Google Scholar 

  23. Meyn, R.E., Corry, P.M., Fletcher, S.E., and Demetriades, M. Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum (II). Cancer Res. 40: 1136–1139, 1980.

    PubMed  CAS  Google Scholar 

  24. Myers, C.E. The use of intraperitoneal chemotherapy in the treatment of ovarian cancer. Sem. Oncol. 11: 275–284, 1984.

    CAS  Google Scholar 

  25. Myers, C.E., and Collins, J.M. Pharmacology of intraperitoneal chemotherapy. Cancer Invest. 1: 395–407, 1983.

    Article  PubMed  CAS  Google Scholar 

  26. Omura, G., Blessing, J.A., Ehrlich, C.E., et al. A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. Cancer 57: 1725–1730, 1986.

    Article  PubMed  CAS  Google Scholar 

  27. Ozols, R.F., Behrens, B.C., Ostchega, Y., and Young, R.C. High dose cisplatin and high dose carboplatin in refractory ovarian cancer. Cancer Treat. Rep. 12: 59–65, 1985.

    CAS  Google Scholar 

  28. Riviere, J.E., Page, R.L., Dewhirst, M.W., Tyczkowska, K., and Thrall, D.E. Effect of hyperthermia on cisplatin pharmacokinetics in normal dogs. Int. J. Hypertherm. 2: 351–358, 1986.

    Article  CAS  Google Scholar 

  29. Robins, H.I., Dennis, W.H., Neville, A.J., Shecterle, L.M., Martin, P.A., Grossman, J., Davis, T.E., Neville, S.R., Gillis, W.K., and Rusy, B.F. A nontoxic system for 41.8°C whole body hyperthermia: Results of a Phase I study using a radiant heat device. Cancer Res. 45: 3937–3944, 1985.

    PubMed  CAS  Google Scholar 

  30. ten Bokkel Huinink, W.W., Dubbelman, R., Aartsen, E., Franklin, H., and McVie, J.G. Experimental and clinical results with intraperitoneal cisplatin. Sem. Oncol. 12: 43–46, 1985.

    Google Scholar 

  31. Thrall, D.E., Page, R.L., Dewhirst, M.W., Meyer, R.E., Hoopes, P.J., and Kornegay, J.N. Temperature measurements in normal and tumor tissue of dogs undergoing whole body hyperthermia. Cancer Res. 46: 6229–6235, 1986.

    PubMed  CAS  Google Scholar 

  32. Wallner, K.E., DeGregorio, M.W., and Li, G.C. Hyperthermie potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in Chinese hamster ovary cells resistant to the drug. Cancer Res. 46: 6242–6245, 1986.

    PubMed  CAS  Google Scholar 

  33. Wiltshaw, E., Evans, B., and Harland, S. Phase III randomised trial of cisplatin versus JM8 (carboplatin) in 112 ovarian cancer patients, stages III and IV. Abstract, Proc. Amer. Soc. Clin. Oncol. 4: 121, 1985.

    Google Scholar 

  34. Wondergem, J., Bulger, R.E., Strebel, F.R., Newman, R.A., Travis, E.L., Stephens, L.C., and Bull, J.M.C. Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury. Cancer Res. 48: 440–446, 1988.

    PubMed  CAS  Google Scholar 

  35. Zakris, E.L., Dewhirst, M.W., Riviere, J.E., Hoopes, P.J., Page, R.L., and Oleson, J.R. Pharmacokineties and toxicity of intraperitoneal cisplatin combined with regional hyperthermia. J. Clin. Oncol. 5: 1613 1620, 1987.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Human Oncology, University of Wisconsin, 600 Highland Avenue, Madison, Wisconsin, 53792, USA

    Justin D. Cohen (Clinical Research Fellow)

  2. Departments of Human Oncology, Medicine, Neurology and Veterinary Medicine, University of Wisconsin, 600 Highland Avenue, Madison, Wisconsin, 53792, USA

    H. Ian Robins (Associate Professor)

Authors
  1. Justin D. Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Ian Robins
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Valley Cancer Institute, Los Angeles, California, USA

    Haim I. Bicher M.D.

  2. Emory Clinic, Atlanta, Georgia, USA

    John R. McLaren

  3. II University of Rome, Rome, Italy

    Giuseppe M. Pigliucci

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Plenum Press, New York

About this chapter

Cite this chapter

Cohen, J.D., Robins, H.I. (1990). Whole Body Hyperthermia and Intraperitoneal Carboplatin in Residual Ovarian Cancer. In: Bicher, H.I., McLaren, J.R., Pigliucci, G.M. (eds) Consensus on Hyperthermia for the 1990s. Advances in Experimental Medicine and Biology, vol 267. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5766-7_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5766-7_18

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5768-1

  • Online ISBN: 978-1-4684-5766-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation